STAT1 is frequently down-regulated in various types of human cancer, such as breast cancer, head and neck cancer, multiple myeloma and leukemia [8, 9], and these findings are in line with the postulated role of STAT1 as a tumor suppressor. This evidence concerns the gene STAT1 and AL amyloidosis.